Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Encapsulated mesenchymal stem cells for in vivo immunomodulation

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Prockop DJ . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71–74.

    Article  CAS  PubMed  Google Scholar 

  2. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell transplantation 2010; 19: 667–679.

    Article  PubMed  Google Scholar 

  3. Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci U S A 2011; 108: 17384–17389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tolar J, Villeneuve P, Keating A . Mesenchymal stromal cells for graft-versus-host disease. Human gene therapy 2011; 22: 257–262.

    Article  CAS  PubMed  Google Scholar 

  6. Baker M . Stem-cell drug fails crucial trials. Nature News 2009; 9 September 2009.

  7. Rubio D, Garcia S, De la Cueva T, Paz MF, Lloyd AC, Bernad A et al. Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res 2008; 314: 691–698.

    Article  CAS  PubMed  Google Scholar 

  8. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371–379.

    Article  CAS  PubMed  Google Scholar 

  9. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362–1369.

    Article  CAS  PubMed  Google Scholar 

  10. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP . Stem cell transplantation: the lung barrier. Transplant Proc 2007; 39: 573–576.

    Article  CAS  PubMed  Google Scholar 

  11. de Vos P, Hoogmoed CG, Busscher HJ . Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 2002; 60: 252–259.

    Article  CAS  PubMed  Google Scholar 

  12. Dufrane D, Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P . The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 2006; 27: 3201–3208.

    Article  CAS  PubMed  Google Scholar 

  13. Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN et al. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia 2011; 13: 716–725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA . Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582–2591.

    Article  CAS  PubMed  Google Scholar 

  15. Christensen ME, Turner BE, Sinfield LJ, Kollar K, Cullup H, Waterhouse NJ et al. Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease. Haematologica 2010; 95: 2102–2110.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mezey E . The therapeutic potential of bone marrow-derived stromal cells. J Cell Biochem 2011; 112: 2683–2687.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Marta Lezama for assistance and Alberto Mantovani for helpful discussions and critical reading of the paper. This work has been supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC, ‘Lombardia Molecular Imaging’), Ministero della Salute (Bando cellule staminali, Bando Giovani Ricercatori) and European Community 7th Framework Programme (TIMER project). We would like to thank ‘Fondazione Matilde Tettamanti’, ‘Comitato Maria Letizia Verga’, ‘Comitato Stefano Verri’, ‘Fondazione MBBM’ and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil) for their support. AS was supported by Inserm, France and Fondazione Fondazione Cassa di Risparmio delle Provincie Lombarde (grant 5808/2007). MC was supported by a fellowship from European Community 6th Framework Programme INNOCHEM project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Zanotti.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zanotti, L., Sarukhan, A., Dander, E. et al. Encapsulated mesenchymal stem cells for in vivo immunomodulation. Leukemia 27, 500–503 (2013). https://doi.org/10.1038/leu.2012.202

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.202

This article is cited by

Search

Quick links